These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36055673)

  • 1. A Scapular Spine Fracture Defined on the Basis of a Bisphosphonate: a Case Report and Review of the Literature.
    Ilyas G; Senyuva G
    Acta Chir Orthop Traumatol Cech; 2022; 89(4):312-314. PubMed ID: 36055673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Femoral insufficiency fractures with bisphosphonate therapy. Cases study.
    Boszczyk A; Kowalski D; Zakrzewski P; Pomianowski S
    Ortop Traumatol Rehabil; 2011; 13(4):403-8. PubMed ID: 21857071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of incomplete atypical femoral fractures in patients after a prolonged and variable course of bisphosphonate therapy-a long-term radiological follow-up.
    Png MA; Mohan PC; Koh JSB; Howe CY; Howe TS
    Osteoporos Int; 2019 Dec; 30(12):2417-2428. PubMed ID: 31435684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Atypical femoral fractures in bisphosphonate therapy].
    Ballaschk A; Kalaitzis N; Röpke M; Piatek S
    Unfallchirurg; 2015 Jan; 118(1):88-91. PubMed ID: 24352201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Femoral insufficiency fractures associated with prolonged bisphosphonate therapy.
    Isaacs JD; Shidiak L; Harris IA; Szomor ZL
    Clin Orthop Relat Res; 2010 Dec; 468(12):3384-92. PubMed ID: 20809164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate-associated atypical fracture of the femur: Spontaneous healing with drug holiday and re-appearance after resumed drug therapy with bilateral simultaneous displaced fractures--a case report.
    Puah KL; Tan MH
    Acta Orthop; 2011 Jun; 82(3):380-2. PubMed ID: 21561306
    [No Abstract]   [Full Text] [Related]  

  • 7. Is surgery necessary for femoral insufficiency fractures after long-term bisphosphonate therapy?
    Ha YC; Cho MR; Park KH; Kim SY; Koo KH
    Clin Orthop Relat Res; 2010 Dec; 468(12):3393-8. PubMed ID: 20865463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 5-year follow-up of a cortical stress fracture resulting in a spontaneous atypical subtrochanteric femoral fracture in a female patient with severe osteoporosis and bisphosphonate therapy over 15 years.
    Haschka J; Kühne F; Muschitz C; Pirker T; Kocijan R; Bittighofer C; Trubrich A; Resch H
    Wien Klin Wochenschr; 2011 Nov; 123(21-22):684-7. PubMed ID: 21837437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathogenesis of atypical femoral fracture].
    Iwata K; Mashiba T
    Clin Calcium; 2016 Jan; 26(1):73-9. PubMed ID: 26728533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral femur fractures associated with short-term bisphosphonate use.
    Rifai A; Pourtaheri S; Carbone A; Callaghan JJ; Stadler CM; Record N; Issa K
    Orthopedics; 2015 Feb; 38(2):e139-42. PubMed ID: 25665120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential subtrochanteric femoral fracture after atypical diaphyseal fracture in a long-term bisphosphonate user: a case report.
    Park KT; Lee KB
    Acta Chir Orthop Traumatol Cech; 2015; 82(2):157-60. PubMed ID: 26317188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obliteration of the medullary canal in an atypical bisphosphonate-related femoral fracture.
    Cawley DT; Barrett HL; Harrington P
    BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25568263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of bisphosphonate-associated femoral fractures.
    Shkolnikova J; Flynn J; Choong P
    ANZ J Surg; 2013 Mar; 83(3):175-81. PubMed ID: 23216704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dichotomous location of 160 atypical femoral fractures.
    Koeppen VA; Schilcher J; Aspenberg P
    Acta Orthop; 2013 Dec; 84(6):561-4. PubMed ID: 24286566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series.
    Bögl HP; Aspenberg P; Schilcher J
    Osteoporos Int; 2017 Aug; 28(8):2439-2444. PubMed ID: 28474166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral atypical femur fractures without bisphosphonate exposure.
    Szolomayer LK; Ibe IK; Lindskog DM
    Skeletal Radiol; 2017 Feb; 46(2):241-247. PubMed ID: 27900455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective review of patients with atypical bisphosphonate related proximal femoral fractures.
    Phillips HK; Harrison SJ; Akrawi H; Sidhom SA
    Injury; 2017 Jun; 48(6):1159-1164. PubMed ID: 28410753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate-associated fractures of the femur: pathophysiology and treatment.
    Einhorn TA; Bogdan Y; Tornetta P
    J Orthop Trauma; 2014 Jul; 28(7):433-8. PubMed ID: 24121986
    [No Abstract]   [Full Text] [Related]  

  • 19. Bisphosphonates and atypical femoral fractures: Is the location of the fracture associated with the time of consolidation?
    Llano L; Barla J; Taype D; Garcia Barreiro G; Sancineto C; Carabelli G
    Injury; 2023 Nov; 54 Suppl 6():110730. PubMed ID: 38143116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study.
    Lenart BA; Neviaser AS; Lyman S; Chang CC; Edobor-Osula F; Steele B; van der Meulen MC; Lorich DG; Lane JM
    Osteoporos Int; 2009 Aug; 20(8):1353-62. PubMed ID: 19066707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.